Therapy for dyskinesias in Parkinson’s disease patients

By Stefani Alessandro   Pierantozzi Mariangela   Koch Giacomo   Galati Salvatore   Stanzione Paolo  

Future Neurology, Vol. 5, Iss. 2, 2010-03 ,pp. : 277-299

Future Medicine

Access to resources Recommend Favorite

Force overflow and levodopa-induced dyskinesias in Parkinson’s disease

By Wenzelburger R.   Zhang B-R.   Pohle S.   Klebe S.   Lorenz D.   Herzog J.   Wilms H.   Deuschl G.   Krack P.  

Brain, Vol. 125, Iss. 4, 2002-04 ,pp. : 871-879

Oxford University Press

Access to resources Recommend Favorite

Increased adenosine A 2A receptors in the brain of Parkinson’s disease patients with dyskinesias

By Calon Frédéric  

Brain, Vol. 127, Iss. 5, 2004-05 ,pp. : 1075-1084

Oxford University Press

Access to resources Recommend Favorite

The influence of levodopa-induced dyskinesias on manual tracking in patients with Parkinson’s disease

By Lemieux Sarah   Ghassemi Mehrdad   Jog Mandar   Edwards Roderick   Duval Christian  

Experimental Brain Research, Vol. 176, Iss. 3, 2007-01 ,pp. : 465-475

Springer Publishing Company

Access to resources Recommend Favorite

Cellular Distribution of NMDA Glutamate Receptor Subunit mRNAs in the Human Cerebellum

By Scherzer C.R.   Landwehrmeyer G.B.   Kerner J.A.   Standaert D.G.   Hollingsworth Z.R.   Daggett L.P.   Veliçelebi G.   Penney J.B.   Young A.B.  

Neurobiology of Disease, Vol. 4, Iss. 1, 1997-01 ,pp. : 35-46

Academic Press

Access to resources Recommend Favorite